Research Article
Resting Heart Rate Does Not Predict Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients
Table 3
Cumulative incidence of DKD progression, MACE and all-cause mortality in the whole group and subgroups.
| | | DKD progressor | | MACE | | ALL-cause mortality | |
| | Whole group () | 48.3% | — | 23.1% | — | 38.9% | — |
| | CKD-b+ () | 51.5% | NS | 22.3% | NS | 53.0% | NS | | CKD-b− () | 47.1% | 27.3% | 36.1% |
| | DKD-b+ () | 53.4% | 0.047 | 26.8% | 0.023 | 48.4% | <1 × 10−4 | | DKD-b− () | 26.9% | 11.7% | 6.5% |
|
|
